{"disease":{"id":"spinal-and-bulbar-muscular-atrophy","name":"spinal and bulbar muscular atrophy"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03555578","title":"Specified Drug-Use Survey of Leuprorelin Acetate Injection Kit 11.25 mg \"All-Case Investigation: Spinal and Bulbar Muscular Atrophy (SBMA)\"","phase":"","overall_status":"RECRUITING","enrollment_count":1890,"lead_sponsor_name":"Takeda","has_results":false},{"nct_id":"NCT06169046","title":"A Placebo-controlled Study of Clenbuterol in Spinal and Bulbar Muscular Atrophy","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":90,"lead_sponsor_name":"Gianni Soraru","has_results":false},{"nct_id":"NCT02124057","title":"Study of Hepatic Function in Patients With Spinal and Bulbar Muscular Atrophy","phase":"","overall_status":"COMPLETED","enrollment_count":71,"lead_sponsor_name":"National Institute of Neurological Disorders and Stroke (NINDS)","has_results":false},{"nct_id":"NCT04944940","title":"Clinical, Molecular and Imaging Biomarkers in Spinal and Bulbar Muscular Atrophy (SBMA)","phase":"","overall_status":"RECRUITING","enrollment_count":70,"lead_sponsor_name":"National Institute of Neurological Disorders and Stroke (NINDS)","has_results":false},{"nct_id":"NCT06862596","title":"Clinical Trial of Mexiletine Hydrochloride for Spinal and Bulbar Muscular Atrophy","phase":"PHASE2, PHASE3","overall_status":"RECRUITING","enrollment_count":68,"lead_sponsor_name":"Masahisa Katsuno","has_results":false},{"nct_id":"NCT06411912","title":"A Study of NIDO-361 in Patients With SBMA","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":54,"lead_sponsor_name":"Nido Biosciences, Inc.","has_results":true},{"nct_id":"NCT02024932","title":"Safety, Tolerability, and Efficacy of BVS857 in Patients With Spinal and Bulbar Muscular Atrophy","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":37,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT05517603","title":"A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Of AJ201 In Patients","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":25,"lead_sponsor_name":"AnnJi Pharmaceutical Co., Ltd.","has_results":false}],"total":8},"guidelines":[],"source":"Drug Landscape verified database"}